Salvatore Calabrese - 19 May 2022 Form 4/A - Amendment Insider Report for Gain Therapeutics, Inc. (GANX)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Salvatore Calabrese
Issuer symbol
GANX
Transactions as of
19 May 2022
Net transactions value
+$8,100
Form type
4/A - Amendment
Filing time
23 May 2022, 16:00:47 UTC
Date Of Original Report
19 May 2022
Next filing
19 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Purchase $8,100 +3,000 $2.70 3,000 19 May 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.